Haas, R., & Hunstein, W. (1994). Idarubicin/cytosine arabinoside and mitoxantrone/etoposide with rhGM-CSF priming for de novo acute myelogenous leukemia. Acute leukemias ; 4: Prognostic factors and treatment strategies.
Chicago Style (17th ed.) CitationHaas, Rainer, and Werner Hunstein. "Idarubicin/cytosine Arabinoside and Mitoxantrone/etoposide with RhGM-CSF Priming for De Novo Acute Myelogenous Leukemia." Acute Leukemias ; 4: Prognostic Factors and Treatment Strategies 1994.
MLA (9th ed.) CitationHaas, Rainer, and Werner Hunstein. "Idarubicin/cytosine Arabinoside and Mitoxantrone/etoposide with RhGM-CSF Priming for De Novo Acute Myelogenous Leukemia." Acute Leukemias ; 4: Prognostic Factors and Treatment Strategies, 1994.
Warning: These citations may not always be 100% accurate.